MediciNova (MNOV) shares were down than 10% in premarket activity Monday after the company posted the results from a phase 2 clinical trial of its drug MN-001, or tipelukast.
AngloGold Ashanti (AU) stock was 7% lower after a 0.6% increase at Friday's close.
StablecoinX (USDE) shares were down more than 6% following a 21% rise in the prior session.
Coeur Mining (CDE) stock was 6% lower after a 1.5% increase in Friday's session.
Stewards (SWRD) shares were down 5%, extending the 7% loss from the previous close.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments